Cooley Talks Life Sciences

In our first episode, our panel assessed the financing, partnering and M&A trends that shaped the life sciences industry in 2024 – and shared their optimism for 2025.

This episode explores what’s hot – and what’s not – in cross-border partnering deals. Gain key insights into current deal trends and strategic considerations for successfully navigating these complex transactions in 2025.

This episode explores how artificial intelligence (AI) and digital health are reshaping the life sciences industry – from accelerating research and development to transforming commercialization strategies. Our esteemed panel will dive into the evolving investment landscape, spotlighting where capital is flowing, how valuations are shifting, and what companies and investors need to know when adopting AI-powered and digital therapeutic solutions.

In this episode, our panel will unpack how life sciences companies can make the most of their J.P. Morgan Healthcare Conference (JPM) experience. We’ll explore how to build momentum, boost visibility and position your company for meaningful engagement at one of the industry’s most influential events of the year. Plus, our team will break down the current market landscape to help you navigate JPM with confidence and clarity.

This special edition spotlights the evolution of Cooley’s life sciences platform and the women leaders who have shaped – and continue to shape – its growth. From formation and venture financing to partnering, public offerings and market‑defining exits, Cooley hasn’t just witnessed the rise of the life sciences industry – we have helped build it. This session will explore how sustained momentum is driven by deep market insights, strong client partnerships and leadership that constantly pushes the industry forward.